Skip to content
Screener

Neogen NEOG Q1 2027 earnings

Reported October 6, 2026 · After market close

Revenue$222.8MBeat by $14.6M
EPS$0.08Beat by $0.03
Revenue estimate$208.2M
EPS estimate$0.05
“As we entered fiscal year 2027, our focus shifted from strengthening fundamentals to scaling them to drive more consistent execution, improved customer outcomes and profitable growth. Our first-quarter results reflect encouraging progress as the changes underway across the organization continue to take hold. We are strengthening commercial discipline, harmonizing our sales operating model, rebuilding our innovation engine and improving the systems and processes that support inventory optimization and customer service. At the same time, we are making targeted investments to enhance our capabilities and are committed to pursuing further improvements with the goal of building on our momentum to drive more consistent growth and margin expansion over the long term.”
Mike Nassif

Next report

Date not yet announced

Financials

Q1 2027

Income statement

See full
Revenue$222.8M+6.5%
Gross profit$105.5M+11.1%
Operating income-$1.8M+88.8%
Net income-$11.9M-133%
EPS (diluted)-$0.05-129%

Balance sheet

See full
Cash & equivalents$172.0M+23.8%
Total debt$774.2M-2.3%
Total equity$2.1B-1.5%
Total assets$3.3B-2.2%

Cash flow

See full
Operating cash flow$12.9M+19.4%
CapEx$8.2M-65.8%
Free cash flow$4.7M+136%

Valuation & ratios

Valuation

as of 10/09/26
See full
Market cap$2.56B+73.5%
Enterprise value$3.16B+48.5%
P/S2.9×+1.2×

Profitability

See full
Gross margin47.4%+1.0pp
Net margin-6.3%-3.1pp

Returns & leverage

See full
Return on equity-2.7%-1.3pp
Debt / equity0.4×0.0×
Current ratio3.9×+0.3×

Segments

By product

See full
Indicator Testing And Culture Media$85.6M—
Bacterial And General Sanitation$44.6M+7.2%
Genomics Services$24.0M+8.6%
Biosecurity Products$23.5M-6.0%
Natural Toxins And Allergens$19.3M-3.5%

By segment

See full
Food Safety$163.2M+7.3%
Animal Safety$59.6M+4.4%

FAQ

When did Neogen report Q1 2027 earnings?
Neogen (NEOG) reported Q1 2027 earnings on October 6, 2026 after market close.
What were Neogen's Q1 2027 revenue and EPS?
Neogen reported revenue of $222.8M and eps of $0.08 for Q1 2027.
Did Neogen beat estimates in Q1 2027?
Revenue beat the consensus estimate of $208.2M by $14.6M. EPS beat the consensus estimate of $0.05 by $0.03.
How did Neogen's Q1 2027 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 6.5% from $209.2M a year earlier and eps grew 100.0% from $0.04.
Where can I find Neogen's Q1 2027 SEC filings?
You can read the 8-K earnings release (0001193125-26-415544) and the 10-Q periodic report (0001193125-26-416954) directly on SEC EDGAR. The filing index links above go to sec.gov.